Bemfivastatin (PPD 10558) is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin can be used for research of metabolic disease, such as hypercholesterolemia[1][2].
Molecular Weight:
588.67
Purity:
99.48
CAS Number:
[805241-79-6]
Formula:
C34H37FN2O6
Target:
HMG-CoA Reductase (HMGCR)
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
